Higher susceptibility of spontaneous and NNK‐induced lung neoplasms in connexin 43 deficient CD1 × AJ F1 mice: Paradoxical expression of connexin 43 during lung carcinogenesis
暂无分享,去创建一个
H. Fukumasu | G. Mennecier | C. Mori | D. S. Sanches | J. Avanzo | M. Dagli
[1] Sven Diederichs,et al. The hallmarks of cancer , 2012, RNA biology.
[2] C. Lee,et al. Aberrant Wnt1/&bgr;-Catenin Expression is an Independent Poor Prognostic Marker of Non-small Cell Lung Cancer After Surgery , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] C. Naus,et al. Implications and challenges of connexin connections to cancer , 2010, Nature Reviews Cancer.
[4] H. Jiang,et al. Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth , 2009, Cancer Gene Therapy.
[5] M. Mesnil,et al. Gap junctions and cancer: new functions for an old story. , 2009, Antioxidants & redox signaling.
[6] J. Rey-Campos,et al. Biological effects of FoxJ2 over-expression , 2008, Transgenic Research.
[7] K. Willecke,et al. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium , 2008, BMC medicine.
[8] A. Moorman,et al. Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43. , 2008, Cardiovascular research.
[9] B. Mayr,et al. bZIP-Type transcription factors CREB and OASIS bind and stimulate the promoter of the mammalian transcription factor GCMa/Gcm1 in trophoblast cells , 2008, Nucleic acids research.
[10] I. Morita,et al. Vitamin K2 suppresses malignancy of HuH7 hepatoma cells via inhibition of connexin 43. , 2008, Cancer letters.
[11] J. Hervé,et al. Aberrant expression and localization of connexin43 and connexin30 in a rat glioma cell line , 2008, Molecular carcinogenesis.
[12] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[13] A. Ben-Ze'ev,et al. β‐Catenin signaling in biological control and cancer , 2007 .
[14] Qing Shao,et al. Connexins and Gap Junctions in Mammary Gland Development and Breast Cancer Progression , 2007, Journal of Membrane Biology.
[15] T. Yoshioka,et al. Pathological Significance of Intracytoplasmic Connexin Proteins: Implication in Tumor Progression , 2007, Journal of Membrane Biology.
[16] F. Hernandez-Blazquez,et al. Roles of Gap Junctions and Connexins in Non-Neoplastic Pathological Processes in which Cell Proliferation Is Involved , 2007, Journal of Membrane Biology.
[17] I. Morita,et al. Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communication. , 2007, Cancer letters.
[18] H. Fukumasu,et al. Deletion of a single allele of Cx43 is associated with a reduction in the gap junctional intercellular communication and increased cell proliferation of mouse lung pneumocytes type II , 2007, Cell proliferation.
[19] Y. Miyagi,et al. Connexin expression in mouse lung tumor. , 2007, Cancer letters.
[20] H. Yamasaki,et al. Altered expression of connexins in urethane-induced mouse lung adenomas. , 2006, Life sciences.
[21] Farin Kamangar,et al. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. Mesnil,et al. Defective gap junctional intercellular communication in the carcinogenic process. , 2005, Biochimica et biophysica acta.
[23] A. R. Thitoff,et al. Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[24] T. Shirai,et al. Transgenic Disruption of Gap Junctional Intercellular Communication Enhances Early but Not Late Stage Hepatocarcinogenesis in the Rat , 2005, Toxicologic pathology.
[25] K. Warner. The role of research in international tobacco control. , 2005, American journal of public health.
[26] Biao He,et al. Wnt signaling in lung cancer. , 2005, Cancer letters.
[27] Anthony J Alberg,et al. Epidemiology of lung cancer: looking to the future. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Jennifer A. Mitchell,et al. Differential activation of the connexin 43 promoter by dimers of activator protein-1 transcription factors in myometrial cells. , 2005, Endocrinology.
[29] P. Lampe,et al. The Gap Junction Protein Connexin32 Is a Mouse Lung Tumor Suppressor , 2004, Cancer Research.
[30] H. Yamasaki,et al. Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. , 2004, Carcinogenesis.
[31] Ajamete Kaykas,et al. WNT and β-catenin signalling: diseases and therapies , 2004, Nature Reviews Genetics.
[32] Ruud H. Brakenhoff,et al. Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.
[33] P. Lampe,et al. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. , 2004, Carcinogenesis.
[34] R. Cardiff,et al. Classification of Proliferative Pulmonary Lesions of the Mouse , 2004, Cancer Research.
[35] Stephen S. Hecht,et al. Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.
[36] Ya‐Wen Cheng,et al. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] Roger A. Jones,et al. K-ras gene sequence effects on the formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-DNA adducts. , 2003, Chemical research in toxicology.
[38] Wei Zhang,et al. Communication between malignant glioma cells and vascular endothelial cells through gap junctions. , 2003, Journal of neurosurgery.
[39] J. Degen,et al. Structural and Functional Diversity of Connexin Genes in the Mouse and Human Genome , 2002, Biological chemistry.
[40] C. Naus. Gap junctions and tumour progression. , 2002, Canadian journal of physiology and pharmacology.
[41] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[42] H. Yamasaki,et al. Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted. , 2000, The Journal of investigative dermatology.
[43] V. Krutovskikh,et al. Role of connexin (gap junction) genes in cell growth control and carcinogenesis. , 1999, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[44] M. Rook,et al. Identification of connexin43 as a functional target for Wnt signalling. , 1998, Journal of cell science.
[45] S. Hecht,et al. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.
[46] G. Yang,et al. Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus. , 1998, Carcinogenesis.
[47] J. Trosko,et al. Localization and function of the connexin 43 gap‐junction protein in normal and various oncogene‐expressing rat liver epithelial cells , 1996, Molecular carcinogenesis.
[48] N. Gilula,et al. The Gap Junction Communication Channel , 1996, Cell.
[49] B L Langille,et al. Cardiac malformation in neonatal mice lacking connexin43. , 1995, Science.
[50] K. Willecke,et al. Negative growth control of HeLa cells by connexin genes: connexin species specificity. , 1995, Cancer research.
[51] S. Amin,et al. Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. , 1989, Carcinogenesis.
[52] W. Loewenstein,et al. Intercellular Communication and the Control of Tissue Growth: Lack of Communication between Cancer Cells , 1966, Nature.
[53] A. Ben-Ze'ev,et al. beta-Catenin signaling in biological control and cancer. , 2007, Journal of cellular biochemistry.
[54] L. Aicher,et al. Aberrant beta-catenin signaling in tuberous sclerosis. , 2005, The American journal of pathology.
[55] L. Aicher,et al. Molecular Pathogenesis of Genetic and Inherited Diseases Aberrant (cid:1) -Catenin Signaling in Tuberous Sclerosis , 2005 .
[56] Randall T Moon,et al. WNT and beta-catenin signalling: diseases and therapies. , 2004, Nature reviews. Genetics.
[57] Kathleen R. Cho,et al. Role of (cid:1) -Catenin/T-Cell Factor-Regulated Genes in Ovarian Endometrioid Adenocarcinomas , 2002 .
[58] V. Krutovskikh,et al. Connexin genes and cell growth control. , 1996, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[59] M. Djordjevic,et al. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. , 1994, Journal of toxicology and environmental health.
[60] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.